Rossby Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$115K Buy
296
+62
+26% +$24.7K 0.02% 658
2026
Q2
$90.5K Sell
234
-28
-11% -$10.4K 0.02% 558
2026
Q1
$78.2K Buy
262
+106
+68% +$34.8K 0.02% 612
2025
Q4
$54.7K Buy
156
+72
+86% +$24.3K 0.02% 525
2025
Q3
$27.9K Buy
84
+44
+110% +$13.7K 0.01% 644
2025
Q2
$15.6K Buy
+40
New +$16.1K 0.01% 703

Other funds holding ELV

Rossby Financial's ELV Position: Q3 2026 in Review

Rossby Financial increased its Elevance Health (ELV) stake by 26% in Q3 2026, buying an estimated $24.7K and bringing the position to 296 shares worth $115K. The position accounts for 0.02% of the portfolio, ranked #658.

Rossby Financial first reported a position in ELV in Q2 2025 and has held it in 6 quarters since. 1,629 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Rossby Financial held 296 shares of Elevance Health worth $115K as of Q3 2026.
  • Rossby Financial bought 62 Elevance Health shares in Q3 2026, an estimated $24.7K.
  • Elevance Health made up 0.02% of Rossby Financial's portfolio in Q3 2026, its #658 holding.
  • Rossby Financial first reported a position in Elevance Health in Q2 2025 and has held it in 6 quarters since.
  • 1,629 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.